Telix Pharmaceuticals | TLX - Ebitda


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Telix Pharmaceuticals

Telix Pharmaceuticals Ltd reported AUD-18962000 in EBITDA for its fiscal semester ending in December of 2022.


Ebitda Change
Cochlear COH:AU AUD 232.3M 19.3M
CSL CSL:AU USD 2.6B 1.44B
Integral Diagnostics Ltd IDX:AU AUD 38.71M 1.9M
Mayne Pharma MYX:AU AUD -85185000 90.18M
Pacific Edge PEB:NZ NZD -16125000 2.33M
Paradigm Biopharmaceuticals Ltd PAR:AU AUD -31871180 19.49M
Polynovo Ltd PNV:AU AUD -2536020 1.89M
PYC Therapeutics Ltd PYC:AU AUD -16471090 9.11M
Ramsay Health Care RHC:AU AUD 760.9M 176.9M
ResMed RMD:AU USD 326.37M 13.62M
Sonic Healthcare SHL:AU AUD 924.61M 367.46M